Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Oral misoprostol as first-line care for incomplete abortion in Burkina Faso
International Journal of Gynecology and Obstetrics, Volume 119, No. 2, Year 2012
Notification
URL copied to clipboard!
Description
Objective: To explore 400-μg sublingual misoprostol as primary treatment in lower-level facilities with no previous experience providing postabortion care. Methods: Women presenting with incomplete abortion were offered a single dose of 400-μg sublingual misoprostol. Incomplete abortion was defined as uterine size consistent with fewer than 12 weeks of gestation, open cervical os, and reports of past or present history of vaginal bleeding. Women returned to the clinic 1 week after misoprostol administration for follow-up. At that time, they were discharged if the uterine evacuation was a success or were offered a second follow-up visit or surgical completion if still incomplete. Results: One-hundred women received misoprostol; outcome data were unavailable for 1 woman. Complete uterine evacuation was achieved for 97 (98.0%) women. Satisfaction was high, with nearly all women indicating that they were satisfied (n = 57 [57.6%]) or very satisfied (n = 41 [41.4%]) with their experience. Adverse effects were considered tolerable by 72 of 97 (74.2%) women. Ninety-seven of 99 (98.0%) participants indicated that they would choose misoprostol for incomplete abortion care in the future and 95 of 97 (97.9%) stated that they would recommend it to a friend. Conclusion: Misoprostol is a viable option for treatment of incomplete abortion at mid-level facilities. Clinical trials.gov: NCT00466999. © 2012 International Federation of Gynecology and Obstetrics.
Authors & Co-Authors
Blandine, Thieba
Burkina Faso, Ouagadougou
University Hospital Yalgado Ouedraogo
Ouattara, Adama Z.
Burkina Faso
Dandé District Hospital
Coral, Angela
United States, New York
Gynuity Health Projects
Hassane, Cisse
Burkina Faso
Dandé District Hospital
Clotaire, Hien
Burkina Faso
Ziniaré District Hospital
Dao, Blami
Burkina Faso
Souro Sanou University Teaching Hospital
Lankoandé, Jean
Burkina Faso, Ouagadougou
University Hospital Yalgado Ouedraogo
Diop, Ayisha
United States, New York
Gynuity Health Projects
Blum, Jennifer
United States, New York
Gynuity Health Projects
Statistics
Citations: 9
Authors: 9
Affiliations: 5
Identifiers
Doi:
10.1016/j.ijgo.2012.05.036
ISSN:
00207292
e-ISSN:
18793479
Research Areas
Health System And Policy
Sexual And Reproductive Health
Study Design
Cohort Study
Study Locations
Burkina Faso
Participants Gender
Female